NEW YORK - eTradeWire -- The Icla da Silva Foundation is proud to welcome Cassio Domingues Neto to our Board of Trustees!

As a longtime supporter of the Icla da Silva Foundation, Cassio brings valuable expertise and a deep commitment to our mission. We're excited for his leadership in helping more patients access critical treatment.

Cassio Domingues Neto is the Director of Business Strategy at the Taurus Group within Morgan Stanley, where he has been for nine years. Prior to this, he worked as an Investment Analyst at J.P. Morgan. He holds a Bachelor of Science degree from Babson College with a double concentration in Entrepreneurship and Finance.

A dedicated supporter of the Icla da Silva Foundation for many years, Cassio has played a key role in expanding our network. His expertise in business strategy and deep commitment to our mission makes him a valuable member of our Board of Trustees.

More on eTradeWire News

• Attorney Robyn Sztyndor Featured in Miami Herald Article on South Florida Real Estate Trends
• NaturismRE Calls for Body Acceptance Education in Schools to Tackle Youth Mental Health & Physical Inactivity
• The Trusted Private Lender: Flexi-View Lending
• Only Tints Niagara: Spring Window Tint Special - Free Windshield Ceramic Coating with full tint
• Neural Fusion Signs Genre-Defying Artist Who Dat¿ to the Label

Join us in welcoming Cassio!

Learn more about supporting patients in need, visit our website at https://icla.org

About the Icla da Silva Foundation

The Icla da Silva Foundation was established in 1992 in memory of Icla da Silva, a 13-year-old girl from Brazil diagnosed with leukemia. Her family traveled to New York City in search of a cure.

After two years of treatment, Icla passed away; her matching bone marrow donor was never found.

Before her death, Icla left a note to her mother, assuring her that she was fine and asking her family to help the friends she made during treatment at Memorial Sloan Kettering Cancer Center.

Twelve months later, the Icla da Silva Foundation was founded to help patients in need of a bone marrow transplant. Today, the foundation's mission is to save the lives of patients whose only cure is a bone marrow transplant by providing financial, emotional, and logistical support to remove barriers to treatment.